This differs slightly from our study’s findings and indicates that the association of CHIP with treatment outcomes may be linked to the specific ICI or Chemo received, tumor type, patient ECOG status, or other underlying genetic differences, warranting further exploration and more data generation (6). This evidence concerns the gene STUB1 and neoplasm.